• Türkçe
    • English
    • Deutsch
  • English 
    • Türkçe
    • English
    • Deutsch
  • Login
View Item 
  •   DSpace Home
  • Fakülteler / Faculties
  • Tıp Fakültesi / Faculty of Medicine
  • View Item
  •   DSpace Home
  • Fakülteler / Faculties
  • Tıp Fakültesi / Faculty of Medicine
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

The effect of alendronate sodium on trabecular bone structure in an osteoporotic rat model

Thumbnail
View/Open
pdf_4014.pdf (548.9Kb)
Date
2017
Author
Ozsahin, Esin Tokmak
Cam, Burcu
Dere, Fahri
Kurkcu, Mehmet
Evruke, Cuneyt
Soames, Roger
Oguz, Ozkan
xmlui.mirage2.itemSummaryView.MetaData
Show full item record
Abstract
Objectives: This study aims to investigate the effect of alendronate sodium on trabecular bone structure in an osteoporotic rat model. Materials and methods: Between May 2006 and July 2006, 60 female Wistar Albino rats aged three months were randomly allocated to three groups: sham operated receiving no treatment (Shm); ovariectomized-alendronate receiving 1 mg/kg/day alendronate sodium (Ovx-A), and ovariectomized-vehicle receiving 1 mL/kg/day physiological saline (Ovx-PS). Both Ovx groups received treatment through gastric gavage for 56 days. Results: Densitometric measurements showed that bone mineral density decreased in the Ovx-PS and increased in Ovx-A groups (p<0.05). Biomechanical measurements showed a decrease in the breaking force in the Ovx-PS group and an increase in the Ovx-A group (p<0.05). Histomorphometric measurements showed that the Shm group had normal trabecular structure, while the Ovx-PS group had a less well-formed trabecular structure with a loss in the trabecular number and thickness and a corresponding increase in the trabecular spacing (p<0.05). In the Ovx-A group, there was an improvement in the trabecular structure with an increase in the trabecular number and thickness and a loss in the trabecular space (p<0.05). Conclusion: Our study results suggest that alendronate sodium is a valuable treatment agent for osteoporosis in postmenopausal women.
URI
http://www.ftrdergisi.com/uploads/pdf/pdf_4014.pdf
http://hdl.handle.net/11727/3319
xmlui.mirage2.itemSummaryView.Collections
  • Tıp Fakültesi / Faculty of Medicine [1384]

DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 


Politika
Kullanıcı Rehberi
Başkent Üniversitesi Kütüphanesi
Başkent Üniversitesi

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypeLanguageThis CollectionBy Issue DateAuthorsTitlesSubjectsTypeLanguage

My Account

LoginRegister

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV